DTx Evidence Generation: What can we learn from the Pharma and Medical Device Industries?

The definition of Digital Therapeutics (DTx) is broad,  including many different solutions, making it hard to agree on the evidence generation standards. While DTx are very different from drugs and other medical devices, pharma and medtech companies have years of expertise in generating clinical and health economics evidence. In this meeting, we want to deep dive into what learnings the DTx industry can take from them and how should the standards evolve to capture the nuances of this new type of therapy. Join this meeting to have a peer-to-peer conversation about: